• Home
  • Resources
  • About
  • Agenda
  • Symposium
  • Login
  • Subscrib
  • Home
  • About
  • Resources
  • Agenda
  • Symposium
  • Profile
    • Log out
  • Sign in
    • Subscrib

What is the current state of research on long-term therapy using PARP inhibitors in patients with BRCA mutations?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

What are the key findins of the PATINA trial for patients with hormone receptor-positive, HER2-positive metastatic breast cancer ?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

What are the update of DESTINY BREAST 12 in HER2 positive disease with brain metastatis ?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

Copyright © 2025 - BCU

  • Privacy Policy
  • Mentions légales
  • Contact

Our website uses cookies to provide you the best experience. However, by continuing to use our website, you agree to our use of cookies. For more information, read our Cookie Policy.